FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia
- 23 December 2003
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 60 (1) , 18-24
Abstract
BACKGROUND: Fibroblast growth factors (FGFs) are known to play an important role in the growth of prostatic epithelial cells. Benign prostatic hyperplasia (BPH) is characterized by increased epithelial and stromal proliferation within the transition zone of the prostate. FGF2, FGF7, and FGF9 are expressed in BPH tissue but expression of FGF17 has not been previously characterized in human prostate tissue.METHODS: Expression of FGF17 in human prostate tissue and primary cultures of prostatic epithelial and stromal cells was determined by reverse‐transcriptase polymerase chain reaction (RT‐PCR). Growth response to FGF17 was assessed by addition of recombinant FGF17 to immortalized normal and neoplastic epithelial cell lines and primary cultures of prostatic stromal cells in the presence of insulin. Quantitative analysis of expression of FGF17 relative to keratin 18 and/or β‐actin in normal and hyperplastic prostate and prostate carcinoma was carried out by real‐time quantitative RT‐PCR.RESULTS: FGF17 is expressed by prostatic epithelial cells and can act as an autocrine growth factor for immortalized and neoplastic prostatic epithelial cells. It can also promote stromal proliferation, although only at higher concentrations. Expression of FGF17 per epithelial cell was increased 2‐fold in BPH.CONCLUSIONS: FGF17 is expressed by normal, hyperplastic, and neoplastic prostatic epithelial cells and can promote epithelial proliferation in an autocrine manner. FGF17 expression is increased 2‐fold in BPH and may contribute to the increased epithelial proliferation seen in this disease.Keywords
This publication has 17 references indexed in Scilit:
- Fibroblast growth factorsGenome Biology, 2001
- FGF7 AND FGF2 ARE INCREASED IN BENIGN PROSTATIC HYPERPLASIA AND ARE ASSOCIATED WITH INCREASED PROLIFERATIONJournal of Urology, 1999
- FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cellsJournal of Cellular Physiology, 1999
- Genomic structure, mapping, activity and expression of fibroblast growth factor 17Mechanisms of Development, 1999
- Identification and characterization of a novel member of the fibroblast growth factor familyEuropean Journal of Neuroscience, 1998
- Structure and Expression of a Novel Fibroblast Growth Factor, FGF-17, Preferentially Expressed in the Embryonic BrainBiochemical and Biophysical Research Communications, 1998
- Expression of Fibroblast Growth Factors (FGFs) and FGF Receptors in Human ProstateJournal of Urology, 1997
- Receptor Specificity of the Fibroblast Growth Factor FamilyJournal of Biological Chemistry, 1996
- Investigative Urology: Regional Concentration of Basic Fibroblast Growth Factor in Normal and Benign Hyperplastic Human ProstatesJournal of Urology, 1995
- Differential Cytokeratin Expression in Normal, Hyperplastic and Malignant Epithelial Cells From Human ProstateJournal of Urology, 1990